Artificial Intelligence: Vaccine Technology

Lord Markham Excerpts

Thursday 9th July 2026 Lords Chamber

[Lord Vallance of Balham (Lab)]

The MHRA is one of the most important and best regulators in the world for medicines, and none of the requirements for an AI-assisted vaccine design is different from those for a normal one. In other words, it has to be looked at in the same way, with the same sort of safety requirements. The MHRA is looking at how it can use AI, but certainly as part of a human-linked process. There will be people making these decisions.

[Lord Markham (Con)]

My Lords, the best recent example of vaccine technology is the pandemic and Covid, and the UK rightly champions the 100-day mission to develop vaccines against any future pandemics. As I am sure the Minister is aware, AI can rapidly compress that discovery phase through genomic surveillance, lab validation and manufacturing. Given that, how is AI being incorporated into the 100-day mission?

[Lord Vallance of Balham (Lab)]

As the noble Lord says, the 100-day mission was endorsed at the 2021 G7, and I was very involved in that process. AI will be a critical part of how we do vaccines, therapeutics and diagnostics, and I am optimistic that this makes the 100-day mission really achievable, particularly for vaccines. But—and this is an important but—not for all organisms: it is not always the case that you can get a vaccine.